Skip navigation

DSpace JSPUI

DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets

Learn More
DSpace logo
English
中文
  • Browse
    • Communities
      & Collections
    • Publication Year
    • Author
    • Title
    • Subject
    • Advisor
  • Search TDR
  • Rights Q&A
    • My Page
    • Receive email
      updates
    • Edit Profile
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 微生物學科所
Please use this identifier to cite or link to this item: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72573
Title: Siglec-5和Siglec-14受體對於巨噬細胞極化的影響
The role of Siglec-5 and Siglec-14 in macrophage polarization
Authors: Yu-Chang Ku
顧育彰
Advisor: 張永祺(Yung-Chi Chang)
Keyword: Siglecs,巨噬細胞極化,腫瘤相關巨噬細胞,
Siglecs,macrophage polarization,tumor-associated macrophages,
Publication Year : 2019
Degree: 碩士
Abstract: 巨噬細胞是具有高度可塑性的免疫細胞,會因為其遇到的微環境而被極化為M1或M2巨噬細胞,對於維持生理功能的恆定性相當重要。Siglec-5和Siglec-14為主要表現於巨噬細胞上的配對型受體,兩者在配體結合位具有極高的相似性,能在相同配體的刺激下分別經由本身的細胞內ITIM motif (Siglec-5)或是結合具有ITAM motif的DAP12 (Siglec-14)來傳遞相反的訊息。此外,腫瘤細胞可藉由其唾液酸修飾蛋白去鍵結巨噬細胞上的Siglecs受體來調控巨噬細胞極化成腫瘤相關巨噬細胞的能力,因此,本篇論文主要想探討巨噬細胞上的Siglec-5/14配對型受體在巨噬細胞分別被極化為M1、M2或是腫瘤相關巨噬細胞時所扮演的角色。我們會先利用LPS/IFN-γ和IL-4/IL-13來建立巨噬細胞極化的模式,隨後會將巨噬細胞培養在腫瘤細胞培養液中來研究Siglec-5/14是否可以調控腫瘤相關巨噬細胞形成。首先,經由比較發炎性激素的產生,我們知道表現Siglec-5/14與否並不影響THP-1細胞在LPS/IFN-γ刺激下形成M1巨噬細胞的能力。但表現Siglec-14的THP-1細胞在IL-4/IL-13的刺激能夠表現比較多的M2指標,如CCL18、CCL22、IL-1RA、CD36和CD204,以及表現較高量可促使M2巨噬細胞極化的轉錄因子,如PPAR-γ和LXR-α。我們發現,實驗所用到的三種大腸癌細胞(SW480、SW620、HT29)培養液都能夠促進THP-1細胞形成腫瘤相關巨噬細胞,而肺癌細胞(CL1-0、CL1-5)和乳癌細胞(BT549)則無法極化THP-1成為腫瘤相關巨噬細胞。在大腸癌細胞培養液的處理下,與腫瘤相關巨噬細胞有關的指標會因THP-1細胞表現Siglec-5或是Siglec-14而有所不同。Siglec-14/THP-1細胞能夠產生出較多的CCL18、CCL22、IL-1RA、CD36、CD204和IDO,而Siglec-5/THP-1細胞會產生出較多的IL-10和MMP-9。經由分析多種轉錄因子的表現或是活性,我們認為Siglec-14可能可以在大腸癌細胞培養液的處理下經由促進STAT3的活化和LXR-α的表現來增加TAM指標的表達。總結來說,我們發現在巨噬細胞上的Siglec-5和Siglec-14受體的確能在刺激下影響巨噬細胞的極化,但目前仍不明瞭兩者會透過什麼樣的機制來進行調控。
Macrophages are highly plastic immune cells which can be further polarized into M1 or M2 macrophages in response to their surrounding microenvironment, and they play a critical role in maintaining the physiological homeostasis of the body. Siglec-5 and Siglec-14 are paired receptors primarily expresssing on macrophages and have the same sequence of amino acid in their first two N-terminal domains which are critical for ligand binding. However, Siglec-5 delivers inhibitory signals through its intracellular ITIM motif while Siglec-14 transduces activating signaling through the coupled ITAM-containing adaptor, DAP12, upon ligand engagement. In addition, sialylated glycoproteins derived from tumor cells have been shown to target various Siglec receptors to modulate macrophage polarizing into tumor-associated macrophages (TAMs) which can generate an immunosuppressive and pro-tumoral environment to assist cancer progression. In this study, we aim to investigate the role of Siglec-5 and Siglec-14 in macrophage polarization in response to different environmental cues. We first tried to establish a THP-1 macrophage polarization system driven by LPS/IFN-γ and IL-4/IL-13 stimulation, and a successful polarizing stimulation was proved by examing the expression of classical markers often used to classify the M1 and M2 population. Next, expression of M2/TAM markers of the THP-1 macrophages cultured with the tumor conditional medium were studied to explore the impact of the paired Siglec receptors, Siglec-5 and Siglec-14, in TAM programming. Comparable expression of M1 macrophage markers were observed in the Siglec-5/THP-1 and Siglec-14/THP-1 cells upon LPS/IFN-γ treatment, suggesting that exogenous expression of Siglec-5 and Siglec-14 on THP-1 cells did not affect M1 macrophage polarization. Notably, increased expression of M2-specific markers, CCL18, CCL22, IL-1RA, CD36 and CD204, as well as transcriptional factor involved in M2 polarization, PPAR-γ and LXR-α, were detected in Siglec-14-expressing THP-1 cells upon IL-4/IL-13 treatment. Moreover, we found that conditional mediums (CMs) derived from all the tested colorectal cancer cells (SW480, SW620 and HT29) successfully induce THP-1 macrophage differentiating into TAMs, while CM derived from lung cnacer cells (CL1-0 and CL1-5) and breast cancer cells (BT549) failed to achieve the same effects in our experimental condition. Importantly, Siglec-5 and Siglec-14 differentially regulated the TAM-related markers expression of the THP-1 macrophages stimulated with colon cancer CMs. Siglec-14/THP-1 cells expressed more CCL18, CCL22, IL-1RA, CD36, CD204 and IDO, while Siglec-5/THP-1 cells generated more IL-10 and MMP-9. Siglec-14 may induce the activation of STAT3 and the transcription of LXR-α to facilitate TAM formation upon colon cancer CM treatment. In conclusion, our results demonstrate that Siglec-5 and Siglec-14 can modulate the polarization of macrophages in response to IL-4/IL-13 and colon cancer CM, but further studies are required to elucidate the involved mechanisms.
URI: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72573
DOI: 10.6342/NTU201902354
Fulltext Rights: 有償授權
Appears in Collections:微生物學科所

Files in This Item:
File SizeFormat 
ntu-108-1.pdf
  Restricted Access
2.58 MBAdobe PDF
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved